Prophylactic use of eculizumab during surgery in chronic cold agglutinin disease

Primary chronic cold agglutinin disease (CAD) is an autoimmune haemolytic anaemia in which a specific bone marrow lymphoproliferative disorder causes production of cold agglutinins (CA). Binding of CA to erythrocyte surface antigens results in a predominantly extravascular haemolysis that is entirel...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMJ Case Rep
Päätekijät: Tjønnfjord, Eirik, Vengen, Øystein A, Berentsen, Sigbjørn, Tjønnfjord, Geir Erland
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Case Reports 2017
Aiheet:
Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5612509/
https://ncbi.nlm.nih.gov/pubmed/28487302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2016-219066
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia